Red Mountain Compounding Recalls Vitamin D3 Injection Due to Sterility Concerns
Red Mountain Compounding Pharmacy is recalling specific lots of Vitamin D3 10,000 IU/mL oil injection due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for drug recalls involving potential serious health consequences.
Plain-English summary
First Royal Care Co. LLC, doing business as Red Mountain Compounding Pharmacy, is recalling specific lots of S-VITAMIN D3 10,000 IU/ML OIL MDV INJ. The product is a prescription-only medication available in 5ml and 10ml glass vials. The recall was initiated because of a lack of assurance of sterility.
The affected product was distributed nationwide in the USA. The recall covers 16 specific 5ml and 10ml glass vials identified by the following lot numbers and expiration dates: S04092019DT@16 (Exp 8/9/19), S05012019DT@08 (Exp 9/1/19), S05152019DT@01 (Exp 9/15/19), S06112019DH@18 (Exp 10/11/19), S06122019DT@06 (Exp 10/12/19), S06192019DT@10 (Exp 10/19/19), s07092019dt@16 (Exp 11/9/19), and S07242019DH@10 (Exp 11/24/19).
Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates. If the product matches the recalled lots, it should be discontinued and returned to the pharmacy or manufacturer for disposal or credit.
The recalled product
- Product
- S-VITAMIN D3 10,000 IU/ML OIL MDV INJ, Rx Only, a) 5ml b) 10 ML glass vial. Red Mountain Compounding Rx.
- Category
- Drug — Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- Lot #: S04092019DT@16
- Exp 8/9/19
- S05012019DT@08
- Exp 9/1/19
- S05152019DT@01
- Exp 9/15/19
- S06112019DH@18
- Exp 10/11/19
- S06122019DT@06
- Exp 10/12/19
- S06192019DT@10
- Exp 10/19/19
- s07092019dt@16
- Exp 11/9/19
- S07242019DH@10
- Exp 11/24/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 100 recalled by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 100 products in this recall →Related recalls
Same manufacturer · First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
See all →- SevereMIT/B12 Compounded Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- HighTestosterone Ultra 250MG/ML Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- SevereRed Mountain Compounding Test Cypionate Sterility Assurance Recall
FDA (Drugs) · 2021-11-03
- SevereTEST CYP/PROP Compounded Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- HighTEST CYP 25MG/ML Injectable Lacks Assurance of Sterility
FDA (Drugs) · 2021-11-03
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighKey Pharmacy Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereFolic Acid 10mg/mL Injectable Recalled Due to Sterility Concerns
FDA (Drugs) · 2021-11-03
- SevereUS Compounding Recalls Vitamin D3 Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereMethylcobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2021-11-03
- SevereFDA Recalls Vitamin D3 Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2019-04-24
- SevereRanier's Compounding Laboratory Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2018-08-22